Analysis of 3-line generalized Feistel networks with double SD-functions

被引:4
|
作者
Bogdanov, Andrey [1 ,2 ]
Shibutani, Kyoji [3 ]
机构
[1] Katholieke Univ Leuven, ESAT, COSIC, B-3001 Louvain, Belgium
[2] IBBT, B-3001 Louvain, Belgium
[3] Sony Corp, Minato Ku, Tokyo 1080075, Japan
关键词
Cryptography; Block ciphers; Generalized Feistel networks; Substitution diffusion networks; Differential and linear cryptanalysis; Efficiency; Impossible differential;
D O I
10.1016/j.ipl.2011.04.002
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Generalized Feistel networks (GFN) are broadly employed in the design of primitives for block ciphers, stream ciphers, and hash functions. Lately, endowing the functions of GFNs with the structure of nonlinear substitution followed by linear diffusion (substitution-diffusion. SD) has received a great deal of attention. In this contribution, we prove tight lower bounds on the number of differentially and linearly active S-boxes for 3-line GFNs with double SD-functions where two SD-structures are applied one after another. We also show 8-round impossible differentials for 3-line GFNs with bijective functions. Moreover, we demonstrate that the proportion of active S-boxes in all S-boxes for such GFNs is by up to 14% higher than that for 4-line GFNs with double SD-functions, when instantiated with MDS matrices. This indicates that, rather surprisingly, the 3-line GFNs can be more efficient in practice than those with 4 lines. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:656 / 660
页数:5
相关论文
共 50 条
  • [31] PRECISION OF EMISSION SPECTROCHEMICAL ANALYSIS RESULTS .3. PREPARATION OF SPECTRAL-LINE HOMOLOGY BASED ON SEVERAL PARAMETERS OF SCATTER DIAGRAM AND CALIBRATION FUNCTIONS
    MATHERNY, M
    SPECTROSCOPY LETTERS, 1973, 6 (12) : 711 - 717
  • [32] CLS Next Gen: Accurate Frequency-Frequency Correlation Functions from Center Line Slope Analysis of 2D Correlation Spectra Using Artificial Neural Networks
    Hoffman, David J.
    Fayer, Michael D.
    JOURNAL OF PHYSICAL CHEMISTRY A, 2020, 124 (28): : 5979 - 5992
  • [33] Mutational Analysis of Vaccinia Virus E3 Protein: the Biological Functions Do Not Correlate with Its Biochemical Capacity To Bind Double-Stranded RNA
    Dueck, Kevin J.
    Hu, YuanShen
    Chen, Peter
    Deschambault, Yvon
    Lee, Jocelyn
    Varga, Jessie
    Cao, Jingxin
    JOURNAL OF VIROLOGY, 2015, 89 (10) : 5382 - 5394
  • [34] NATURAL SPIN ORBITAL ANALYSIS OF DIATOMIC MOLECULAR WAVE-FUNCTIONS IN TERMS OF GENERALIZED DIATOMIC ORBITALS .3. VARIABLE SCREENING MODELS FOR SOME EXCITED-STATES OF HEH+
    HELFRICH, K
    THEORETICA CHIMICA ACTA, 1979, 52 (03): : 163 - 170
  • [35] ANALYSIS OF SINGLE-CRYSTAL AND DOUBLE-CRYSTAL SPECTROMETERS USING 3-DIMENSIONAL DUMOND DIAGRAMS AND THE HIGH-PRECISION MEASUREMENT OF THE CU K-ALPHA-1 LINE-PROFILE
    XU, SS
    CHEN, JY
    LI, RS
    JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1988, 21 : 218 - 223
  • [36] Subgroup analysis of elderly patients (pts) in ALTER0303: Anlotinib hydrochloride as 3rd-line and further line treatment in refractory advanced NSCLC pts from a randomized, double-blind, placebo-controlled phase III ALTER0303 trial
    Shi, Jianhua
    Han, Baohui
    Li, Kai
    Wang, Qiming
    Zhang, Li
    Wang, Zhehai
    Cheng, Ying
    He, Jianxing
    Shi, Yuankai
    Chen, Weiqiang
    Wang, Xiuwen
    Luo, Yi
    Nan, Kejun
    Jin, Faguang
    Li, Baolan
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [37] IMPACT OF TUMOR BURDEN ON THE OVERALL SURVIVAL ANALYSIS OF THE LUME-LUNG 1 STUDY: A RANDOMIZED, DOUBLE-BLIND PHASE 3 TRIAL OF NINTEDANIB (BIBF 1120) + DOCETAXEL IN NSCLC PATIENTS PROGRESSING AFTER FIRST-LINE CHEMOTHERAPY
    Reck, Martin
    Novello, Silvia
    Mellemgaard, Anders
    Orlov, Sergei
    Kaiser, Rolf
    Barrueco, Jose
    Gaschler-Markefski, Birgit
    Douillard, Jean-Yves
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S196 - S196
  • [38] Final progression-free survival analysis of JUPITER-02, a randomized, double-blind, phase 3 study of toripalimab or placebo plus gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma.
    Mai, Hai-Qiang
    Chen, Qiu-Yan
    Chen, Dongping
    Hu, Chaosu
    Yang, Kunyu
    Wen, Jiyu
    Li, Jingao
    Shi, Yingrui
    Jin, Feng
    Xu, Ruilian
    Pan, Jianji
    Qu, Shenhong
    Li, Ping
    Hu, Chunhong
    Liu, Yi-Chun
    Jiang, Yi
    He, Xia
    Wang, Hung-Ming
    Lim, Wan-Teck
    Xu, Rui-Hua
    CANCER RESEARCH, 2022, 82 (12)
  • [39] Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial
    Gutzmer, Ralf
    Stroyakovskiy, Daniil
    Gogas, Helen
    Robert, Caroline
    Lewis, Karl
    Protsenko, Svetlana
    Pereira, Rodrigo P.
    Eigentler, Thomas
    Rutkowski, Piotr
    Demidov, Lev
    Manikhas, Georgy Moiseevich
    Yan, Yibing
    Huang, Kuan-Chieh
    Uyei, Anne
    McNally, Virginia
    McArthur, Grant A.
    Ascierto, Paolo A.
    LANCET, 2020, 395 (10240): : 1835 - 1844
  • [40] Retrospective evaluation of the futility analysis in LUME Lung 2, a randomized, double-blind, placebo-controlled phase 3 trial of nintedanib (BIBF 1120) in combination with pemetrexed in NSCLC patients progressing after one prior first line chemotherapy
    Hanna, N.
    Kaiser, R.
    Kim, J. H.
    Sullivan, R.
    Aren, O.
    Ahn, M. J.
    Tiangco, B. J.
    Voccia, I.
    Barrueco, J.
    Glomb, P.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S802 - S802